Morgan Stanley Call 675 LONN 20.0.../ DE000MG83XA5 /
| 10/01/2025 12:14:28 | Chg.-0.010 | Bid13:46:12 | Ask13:46:12 | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 0.089EUR | -10.10% | 0.091 Bid Size: 100,000 |
0.096 Ask Size: 100,000 |
LONZA N | 675.00 CHF | 20/06/2025 | Call |
GlobeNewswire
26/08/2024
Simtra BioPharma Solutions Appoints Dr. Lidia Serina as Head of Development Sciences
GlobeNewswire
23/08/2024
Galapagos announces FDA clearance of IND application for Phase 1/2 ATALANTA-1 study of CD19 CAR-T, G...
GlobeNewswire
08/08/2024
Cabaletta Bio Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
06/08/2024
Vaxcyte Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
14/06/2024
Galapagos presents encouraging new data for CD19 CAR-T candidate GLPG5101 in non-Hodgkin lymphoma at...
GlobeNewswire
30/05/2024
Galapagos and Adaptimmune sign clinical collaboration agreement with an option to exclusively licens...
GlobeNewswire
15/05/2024
Galapagos and Blood Centers of America announce strategic collaboration to accelerate Galapagos’ dec...
GlobeNewswire
08/05/2024
Vaxcyte Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
04/04/2024
Galapagos showcases innovative approach in hematological cancer care with clinical and translational...
GlobeNewswire
04/04/2024
Acumen Pharmaceuticals Collaborates with Lonza to Advance Sabirnetug for the Treatment of Alzheimer’...
GlobeNewswire
27/02/2024
Vaxcyte Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
GlobeNewswire
04/01/2024
Galapagos enters into strategic collaboration agreement with Thermo Fisher Scientific to further exp...
GlobeNewswire
19/12/2023
Galapagos announces start of PAPILIO-1 Phase 1/2 multiple myeloma study of point-of-care manufacture...
GlobeNewswire
09/12/2023
Galapagos presents new encouraging data at ASH 2023 from ongoing CD19 CAR-T studies with GLPG5201 an...
GlobeNewswire
07/12/2023
Galapagos to Host KOL Event on December 10, 2023, at 11:00 AM PST to discuss new data presented at A...
GlobeNewswire
06/11/2023
Vaxcyte Reports Third Quarter 2023 Financial Results and Provides Business Update
GlobeNewswire
16/10/2023
Vaxcyte and Lonza Expand Collaboration for Global Commercial Manufacturing of Broad-Spectrum Pneumoc...
GlobeNewswire
02/10/2023
Repligen Appoints Olivier Loeillot as President and Chief Commercial Officer
GlobeNewswire
20/09/2023
Oxford Biomedica Plc - INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2023